Reduction in perinatal HIV infections in KwaZulu-Natal, South Africa, in the era of more effective prevention of mother to child transmission interventions (2004-2012)

Journal of Acquired Immune Deficiency Syndromes

Volumn 63, Issue 3, 2013, Pages 410-415

  Moodley, Pravi ^a   Parboosing, Raveen ^a   Moodley, Dhayendre ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

HIV; Laboratory data; Prevention of mother to child transmission; South Africa

Indexed keywords

EMTRICITABINE; NEVIRAPINE; TENOFOVIR; ZIDOVUDINE;

ARTICLE; CD4 LYMPHOCYTE COUNT; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; PERINATAL INFECTION; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; SOUTH AFRICA;

ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; SOUTH AFRICA;

EID: 84880228954     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182926931     Document Type: Article

References (41)

1. Joint United Nations Program on HIV/AIDS (UNAIDS). Global report: report on the AIDS epidemic, 2012 global AIDS epidemic 2010. Available at: http://www.unaids.org/documents/20101123-globalreport-em. pdf. Accessed September 27, 2012.
2. Shisana O, Rehle T, Simbayi L, et al. South African National HIV Prevalence, Incidence, Behaviour and Communication Survey, 2008: The Health of Our Children. Cape Town, South Africa: HSRC Press; 2010. Available at: http://www.hsrcpress.ac.za/product.php?productid=2279&freedownload=1. Accessed September 27, 2012.
3. The National Antenatal Sentinel HIV and Syphilis Prevalence Survey, South Africa, 2010. Pretoria, South Africa: National Department of Health; 2011. Available at: http://www.doh.gov.za/docs/reports/2011/hi-v-aids-survey.pdf. Accessed September 19, 2012.
4. Statistics South Africa. Mid-year population estimates, 2011. Statistical release 0302. Available at: http://www.statssa.gov.za/publica-tions/P0302/ P03022011.pdf. Accessed July 25, 2012.
5. Bobat RA, Moodley D, Coutsoudis A, et al. Breastfeeding by HIV-1 infected women and outcome in their infants: a cohort study from Durban, South Africa. AIDS. 1997;11:1627-1633.
6. Dabis F, Bequet L, Ekouevi DK, et al; ANRS 1201/1202 DITRAME PLUS Study Group. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. AIDS. 2005;19: 309-318.
7. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV in Kampala, Uganda: HIVNET012 randomised trial. Lancet. 1999;354:795-802.
8. Connor EM, Sperling RS, Gelber R, et al; For the Paediatric AIDS Clinical Trial Group Protocol 076 study Group. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994;331:1173-1180.
9. Joint United Nations Programme on HIV/AIDS (UNAIDS). Countdown to Zero: Global Plan for the Elimination of New HIV Infections Among Children by 2015 and Keeping Their Mothers Alive, 2011-2015. Geneva, Switzerland: UNAIDS; 2011. Available at: http://www.unaids.org/en/media/unaids/contentassets/documents/ unaidspublication/2011/20110609-JC2137- Global-Plan-Elimination-HIV-Children-en. pdf. Accessed September 19, 2012.
10. World Health Organization. Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector. Progress Report. Geneva, Switzerland: World Health Organization; 2009. Available at: http://www.who.int/ hiv/pub/tuapr-2009-en.pdf. Accessed September 27, 2012.
11. World Health Organization. Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants in Resource-Limited Settings. Towards Universal Access. Recommendations for a Public Health Approach. Geneva, Switzerland: World Health Organization; 2006. Available at: http://www.who.int/ hiv/pub/mtct/arv-guidelines-mtct.pdf. Accessed September 27, 2012.
12. Prevention of mother-to-child transmission of HIV programme (PMTCT), National Department of Health, South Africa (Version 5, 23 May 2001). Available at: http://pmtct.org.za/. Accessed September 20, 2012.
13. National Antiretroviral Treatment Guideline. Pretoria, South Africa: National Department of Health; 2004. Available at: http://www.hst.org. za/uploads/files/sa-ART-Guidelines1.pdf. Accessed on 05 March 2013.
14. Policy and Guidelines for the Implementation of the PMTCT Programme. South Africa: National Department of Health; February 11, 2008. Available at: http://southafrica.usembassy.gov/root/pdfs/2008-pmtct.pdf. Accessed September 27, 2012.
15. South African National AIDS Council. Clinical Guidelines: PMTCT (Prevention of Mother-to-child Transmission) 2010. Pretoria, South Africa: National Department of Health; 2010. Available at: http://www.fidssa.co. za/images/PMTCT-Guidelines.pdf. Accessed September 14, 2012.
16. National HIV and Syphilis Prevalence Survey South Africa 2006. Pretoria, South Africa: Department of Health; 2007. Available at: http://www.info. gov.za/view/DownloadFileAction?id=72528. Accessed September 20, 2012.
17. National HIV and Syphilis Prevalence Survey South Africa 2007. Pretoria, South Africa: Department of Health; 2008. Available at: http://www.unaids.org/ en/dataanalysis/knowyourepidemic/countryreportsonhivestimates/ 20080904-southafrica-anc-2008-en.pdf. Accessed September 19, 2012.
18. The National Antenatal Sentinel HIV and Syphilis Prevalence Survey. Pretoria, South Africa: National Department of Health; 2011.
19. World Health Organization. Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infections in Infants: Recommendations for a Public Health Approach-2010. Geneva, Switzerland: WHO; 2010. Available at: http://whqlibdoc.who.int/publications/2010/9789241599818-eng.pdf. Accessed August 25, 2012.
20. Jackson DJ, Chopra M, Doherty TM, et al; for the Good Start Study Group. Operational effectiveness and 36 week HIV-free survival in the South African programme to prevent mother-to-child transmission of HIV-1. AIDS. 2007;21:509-516.
21. Coetzee D, Hilderbrand K, Boulle A, et al. Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa. Bull World Health Organ. 2005;83:489-494.
22. Rollins N, Little K, Mzolo S, et al. Surveillance of mother-to-child transmission prevention programmes at immunization clinics: the case for universal screening. AIDS. 2007;21:1341-1347.
23. Horwood C, Vermaak K, Butler L, et al. Elimination of paediatric HIV in KwaZulu-Natal, South Africa: large scale assessment of interventions for the prevention of mother-to-child transmission. Bull World Health Organ. 2012;90:168-175.
24. Coutsoudis A, Pillay K, Kuhn L, et al; HM for the South African Vitamin A Study Group. Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa. AIDS. 2001;15:379-387.
25. Moodley D, Moodley J, Coovadia H, et al; South African Intrapartum Nevirapine Trial (SAINT) Investigators. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis. 2003;187:725-735.
26. Bobat R, Coovadia HM, Coutsoudis A, et al. Determinants of mother-to-child transmission of human immunodeficiency virus type 1 infection in a cohort from Durban, South Africa Pediatr Infect Dis J. 1996;15:604-610.
27. Annual report 2011-12, KwaZulu-Natal Department of Health. Available at: http://www.kznhealth.gov.za/1112report/partB.pdf. Accessed February 12, 2013.
28. Evaluating Strategies to reduce mother-to-child transmission of HIV infection in resource-limited Countries (PROMISE). Available at: http://clini-caltrials.gov/show/NCT01061151. Accessed February 13, 2013.
29. The Tshwane declaration of support for breastfeeding in South Africa. S Afr J Clin Nutr. 2011;24:214.
30. Kwazulu-Natal Department of Health annual performance plan 2010/11-2012/13. Available at: http://www.kznhealth.gov.za/app2010-13.pdf Accessed September 21, 2012.
31. Moodley D, Srikewal J, Msweli L, et al. A bird's eye view of PMTCT coverage at two regional hospitals and their referral clinics in a resource-limited setting. S Afr Med J. 2011;101:122-125.
32. Hussain A, Moodley D, Naidoo S, et al. Pregnant women's access to PMTCT and ART services in South Africa and implications for universal antiretroviral treatment. PLoS One. 2011;6:e27907.
33. Goga AE, Dinh TH, Jackson DJ; for the SAPMTCTE study group. Evaluation of the Effectiveness of the National Prevention of Mother-to-Child Transmission (PMTCT) Programme Measured at Six Weeks Postpartum in South Africa, 2010. Pretoria, South African Medical Research Council, National Department of Health of South Africa and PEPFAR/US Centers for Disease Control and Prevention; 2012.
34. Doherty T, Chopra M, Nsibande D, et al. Improving the coverage of the PMTCT programme through a participatory quality improvement intervention in South Africa. BMC Public Health. 2009;9:406.
35. Tubiana R, Le Chenadec J, Rouzioux C, et al. Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load, 500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1). Clin Infect Dis. 2010;50: 585-596.
36. Rundare A, Fatti G, Pududu B, et al. Reduced Vertical Transmission of HIV in Resource Limited Settings-A Comparison Between the 2008 and 2010 National PMTCT Guidelines: South Africa Abstract 1003: 19th Conference on Retroviruses and Opportunistic Infections (CROI). Cape Town, South Africa: Kheth'Impilo AIDS Free Living; March 2012. Available at: http://www.retroconference.org/2012b/ PDFs/1003.pdf. Accessed January 23, 2013.
37. Dinh T-H, Goga A, Jackson D. Impact of South Africa's PMTCT Programs on Perinatal HIV Transmission: Results of the 1st Year Implementing 2010 WHO Recommended Guidelines: 4th International Workshop on Pediatric HIV, Washington DC, July 2012, in Reviews in Antiviral Therapy and Research 2012-8. Abstract O-12. Available at: http://regist2. virology-education.com/abstractbook/2012-8. pdf. Accessed September 26, 2012.
38. Maritz J, Preiser W, Van Zyl GU. Establishing diagnostic cut-off criteria for the COBAS AmpliPrep/COBAS TaqMan HIV-1 Qualitative test through validation against the Amplicor DNA test v1.5 for infant diagnosis using dried blood spots. J Clin Virol. 2012;53:106-109.
39. Feucht UD, Forsyth B, Kruger M. False-positive HIV DNA PCR testing of infants: implications in a changing epidemic. S Afr Med J. 2012;102: 149-152.
40. Bhardwaj S. South Africa announces change in PMTCT regimen from April 1, 2013. Available at: http://www.emtct-iatt.org/2012/12/south-africa-announces- change-in-pmtct-regimen-from-april-1-2013/. Accessed January 25, 2013.
41. HIV/AIDS Programme: Programmatic Update: Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. Geneva, Switzerland: WHO; April 2012. Available at: http://whqlibdoc. who.int/hq/2012/WHO-HIV-2012.6-eng.pdf. Accessed September 23, 2013.